| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1B | $8.3B | $6.8B | $6.8B | $6.5B | $6.1B | $6.1B | $6.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.7B | $2.0B | $1.1B | $1.3B | $1.5B | $1.2B | $1.5B | $1.6B |
| EPS (Basic) | $8.78 | $9.80 | $5.09 | $6.16 | $7.16 | $5.48 | $6.66 | $6.68 |
| EPS (Diluted) | $8.74 | $9.77 | $5.08 | $6.14 | $7.14 | $5.46 | $6.63 | $6.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $177.1B | $155.5B | $150.8B | $155.0B | $183.9B | $170.0B | $136.8B | $132.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $164.2B | $142.7B | $138.9B | $143.8B | $171.9B | $158.3B | $125.7B | $121.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $13.0B | $12.8B | $11.9B | $11.3B | $12.0B | $11.7B | $11.1B | $10.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.5B | $-0.5B | $2.6B | $2.4B | $1.4B | $1.9B | $2.6B | $1.8B |
| Investing Cash Flow | $-20.2B | $-2.6B | $4.8B | $25.9B | $-18.6B | $-29.9B | $-3.4B | $4.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $15.2B | $3.4B | $-7.2B | $-26.4B | $16.1B | $27.9B | $0.6B | $-5.8B |